NaphCare Partners with Washoe County Sheriff’s Office to Launch First-of-Its-Kind Program Why is the correctional system struggling to address the growing mental health crisis among detainees? NaphCare, a leading correctional healthcare company, is addressing this critical issue head-on. Partnering with…
Partnership Aims to Uncover Novel Therapies for Developmental and Epileptic Encephalopathies Why is the discovery of new therapies for genetic epilepsies so critical? Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience, a discovery technology and therapeutics…
biomodal and Element Biosciences Unite for Enhanced Multiomic Insights Why is the integration of multiomic solutions critical in the life sciences industry? biomodal, an omics-based life sciences technology and analytics company, has announced at the AGBT 2026 General Meeting that…
Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic move to solidify its position. The company, which specializes in engineered cytokine…
Global Healthcare Leader Organon Licenses Sebela Pharmaceuticals’ MIUDELLA for Diverse Reproductive Health Needs Why is the landscape of women’s reproductive health evolving so rapidly? Organon a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every…
Flaus Electric Flosser Clinically Proven to Remove 7.74 Times More Plaque Than String Floss Why has the oral care industry lagged behind in innovation for flossing? Flaus, a DTC oral beauty brand, is changing that. Founded by Samantha Coxe, Flaus…
Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is making strategic moves to solidify its position. The company, a clinical-stage biotechnology…
BXLS and Johnson & Johnson Collaborate to Fund Bleximenib Clinical Trials for AML Why is the development of new treatments for acute myeloid leukemia (AML) so critical? Despite being the most common acute leukemia in adults, AML remains an extremely…
Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase 2 registrational study evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in adults…
Merck Evolves Structure to Enhance Commercial Execution and Portfolio Growth In an industry where the pace of innovation and market dynamics are constantly evolving, how can pharmaceutical companies ensure they stay ahead? Merck known as MSD outside of the United States and…